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chieved important reductions in the incidence of Chagas
isease in many Latin American countries. However, this
pproach has been ineffective in some geographic areas
uch as the Gran Chaco. As a result, the development of
ffective new tools in these areas to prevent house rein-
estation by triatomine bugs is a high research priority. No
ess important is the need of innovative approaches includ-
ng those generated from genomics to improve upon existing
iagnostic tests and to develop new parasitological tests
or the early diagnosis of congenital infection in the new-
orn and in immunocompromised patients, as well as for
he assessment of treatment response (PCR; antigenemia,
ecombinant antigens,synthetic peptides etc.). There is also
pressing need of developing new anti-T. cruzi agents with
igh activity in both the acute and chronic phases, and epi-
emiological methods that me may be used to estimate the
revalence of infection, subclinical disease and treatment
eeds in endemic and non-endemic countries.
oi:10.1016/j.ijid.2010.02.1871
9.004
ntegrated control of neglected tropical diseases in Africa
.J. Bockarie
Centre for Neglected Tropical Diseases, Liverpool, United
ingdom
Neglected tropical diseases (NTD) are the ‘other dis-
ases’ of Millennium Development Goal 6 that have received
ittle attention from policy-makers and politicians who
ver focus on HIV, tuberculosis and malaria. They include
any medically diverse diseases that are strongly associ-
ted with poverty. NTDs include bacterial, viral, protozoan
nd helminth infections that have plagued humanity since
ntiquity. Globally, over one billion people suffer from one
r more NTDs and about 500,000 people die from them every
ear.
Neglected Tropical Diseases are widespread in Africa due,
n part, to the low socio-economic status of rural popula-
ions. Many countries are endemic with of 5 or more NTDs
ncluding schistosomiasis, soil-transmitted helminths (STH),
ymphatic ﬁlariasis, onchocerciasis and trachoma, as well
s zoonotic disease such as human African trypanosomiasis,
abies, tick borne relapsing fevers, echinococcus (hydatid),
aeniosis (cysticercosis), brucellosis and plague, with a large
art of the population at risk of co-infection with 2 or more
f these diseases.
Fortunately, control strategies as well as diagnostic tools
nd the availability of safe and effective drugs exist for the
TDs responsible for the greatest burden in Africa: lym-
hatic ﬁlariasis, onchocerciasis, STH and schistosomiasis.
he World Health Organization has developed a strategy,
reventive Chemotherapy and Transmission Control (PCT),
hich is geared towards the implementation of large-scale
ass drug administration. The objective of PCT is to pro-
ide national programmes with technical guidelines that
mphasize a coordinated, cost-effective approach to the
mplementation of national elimination and control activ-
ties where preventive chemotherapy is the main tool, i.e.
egular anthelminthic drug administration to all people at
isk of morbidity due to helminthic diseases, starting early
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n life. The availability of rapid diagnostic tools and dona-
ions of several drugs from pharmaceutical companies, and
he reduced price of other essential antihelminthic drugs
as catalysed the rapid expansion of chemotherapy-based
ontrol programmes for NTDs. The main challenges to PTC
n Africa include poor health service infrastructure in post
onﬂict countries and cost-effective approaches for inte-
rating the individual vertical programmes targeting speciﬁc
iseases.
oi:10.1016/j.ijid.2010.02.1872
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nusual clinical proﬁle of Dengue Infection in patients
ttending a tertiary care teaching hospital in north India
. Agarwal ∗, G. Kapoor, S. Srivastava, K.P. Singh, R. Kumar,
. Jain
C S M Medical University, Lucknow, Uttar pradesh, India
Background: Major outbreaks of dengue virus have been
eported from many parts of North India including Luc-
now, at regular intervals since 1996. We have carried out a
etailed investigation of the Dengue cases occurring in year
008.
Methods: Clinically suspected patients attending Pedi-
trics and Medicine outpatient or inpatient Departments and
eferred to Microbiology Department for serological diagno-
is of dengue, were prospectively enrolled after obtaining
erbal consent. Detailed clinical history and examination
ndings were recorded in a pre designed questionnaire from
98 such patients between Jan 2008 to Dec 2008. Dengue
peciﬁc antibodies were detected using commercial Mac-
LISA kit (IVD, USA). Results of hematological and other
nvestigations were noted from medical records.
Results: Mean age of patients’ was10.25± 10.9 years and
28/398 were in pediatric age group (%12 yrs age). A total of
3.26% (212/398) patients were positive for dengue IgM and
3% of these were admitted patients. Male: Female ratio
as1.8:1 and ∼74% belonged to rural area. Overwhelming
ajority (92%) of dengue cases were seen between July
o November, which are the post monsoon months in this
art of world. Frequent clinical features included fever
100%) withmean duration of 14.07± 9.2 days, edema (50%),
ltered sensorium (39%), rash (31.84%). Mucosal bleeding,
epatomegaly and splenomegaly were present in 31.84%,
7.29% and 56.25% respectively. Thrombocytopenia (58.74%)
as common laboratory ﬁnding. Liver enzymes SGPT and
GOT were raised in 72.55% and 78.43% of positive cases,
espectively. Presentation varied between adults and pedi-
tric populations, while among adults, seizure (p = 0.029),
kin rash (p = 0.029), abdominal pain (p = 0.005) and hemo-
oncentration (PCV > 36; p = 0.063) were signiﬁcant ﬁndings;
owever in children, headache (p = 0.029), serum sodium
nd calcium levels (p = 0.022 and p = .0006) were signif-
cantly raised. Logistic Regression analysis found serum
GOT>40 U/L and presence of splenomegaly as independent
redictors for dengue infection. Only 3 cases met the WHO
riteria for dengue haemorrhagic fever (DHF), however clin-
cally ∼20% of the dengue positive cases were labelled and
trac
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managed as DHF. Mortality rate amongst dengue IgM posi-
tives was 6.02% (5/83).
Conclusion: The unusual clinical proﬁle necessitates
continuous sero surveillance and monitoring for changing
clinical presentationof dengue infection.
doi:10.1016/j.ijid.2010.02.1873
40.002
An outbreak of pneumonia associated with emergent
human adenovirus serotype 14 - Southeast Alaska, 2008
D. Esposito1,∗, T.J. Gardner2, E. Schneider1, L.J.
Stockman1, J. Tate1, C.A. Panozzo1, C.L. Robbins1,
S.A. Jenkerson2, L. Thomas3, C.M. Watson4, A. Curns1,
D.D. Erdman1, X. Lu1, T. Cromeans1, M. Westcott5,
C. Humphries5, J. Ballantyne5, G.E. Fischer1, J.B.
McLaughlin2, G. Armstrong1, L.J. Anderson1
1 Centers for Disease Control and Prevention, Atlanta, GA,
USA
2 Alaska Department of Health and Social Services, Anchor-
age, AK, USA
3 Alicia Roberts Medical Center, Klawock, AK, USA
4 Craig Public Health Center, Craig, AK, USA
5 Alaska State Public Health Virology Laboratory, Fairbanks,
AK, USA
Background: In September 2008, an outbreak of pneumo-
nia associated with a rare human adenovirus (serotype-14
[HAdV-14]) occurred on a rural island in Southeast Alaska.
To determine risk factors for disease and household trans-
mission characteristics, we investigated pneumonia cases in
three affected island communities.
Methods: Case-patients were island residents who pre-
sented to one of two medical clinics with clinical or
radiological evidence of pneumonia between September 1
and October 27, 2008. Controls from the community were
matched 1:1 to case-patients based on age, sex, and com-
munity of residence. Case-patients, controls, and household
contacts were interviewed for information on demograph-
ics, recent illnesses, medical history, ill contacts, and other
possible exposures. Serum and respiratory specimens were
also collected. Risk factors for pneumonia were determined
using exact multivariate conditional logistic regression.
Household HAdV-14 attack rates were calculated.
Results: Thirty-two pneumonia case-patients and 32
matched controls were interviewed. Among case-patients,
the median age was 47.5 (range, 2-95 years), 75% were
male, and 74% were Alaska Native. Nine cases resulted
in hospitalization and there was one death. Twenty-one
(66%) case-patients and no controls were infected with
HAdV-14 (p < 0.001). Independent risk factors for pneu-
monia were contact with a known HAdV-14 pneumonia
case-patient (OR = 18.3, 95%CI = 2.0-&), current smoking
(OR = 6.7, 95%CI = 0.9-&), and having neither traveled off-
island nor attended at a large public gathering (OR = 14.7,
95%CI = 2.0-&). Fourteen (67%) of the 21 HAdV-14-infected
case-patients belonged to a single network of people who
socialized and often smoked together and infrequently trav-
eled off-island. HAdV-14 infection occurred in 43% of case-
versus 5% of control-household contacts (p = 0.005).
g
i
dts e175
Conclusion: This is one of the ﬁrst recognized civil-
an community outbreaks of HAdV-14 since the virus ﬁrst
ppeared in California in 2003. Demographic characteristics
nd illness patterns in case-patients were similar to those
bserved in other HAdV-14 outbreaks in Oregon and Wash-
ngton State in 2007, with disease mostly occurring in adult
ale smokers. In this setting, HAdV-14 appeared to have
pread mostly among close contacts in the home or within
certain social network whose members often reported
moking or sharing smoking materials with other HAdV-14
ase-patients. Lack of HAdV-14 infection in controls and
heir household contacts suggests wide-spread transmission
id not occur, either previously or during this pneumonia
utbreak.
oi:10.1016/j.ijid.2010.02.1874
0.003
ptake and impact of Rotavirus vaccines in US Children
. Cortes1, D. Esposito1, M. Cortese2, D. Bartlett2, J.
ate2, D. Payne2, M. Patel2, A. Curns2, J. Gentsch2, U.
arashar1,∗
CDC, Atlanta, GA, USA
CDC, NCIRD, Atlanta, GA, USA
Background: In 2006 and 2008, two new vaccines were
ecommended for routine vaccination of US infants against
otavirus. We assessed vaccine uptake and its impact on
otavirus disease in US children.
Methods: To measure vaccine uptake, we examined data
rom sentinel immunization information system (IIS) sites
n eight different US locations. Coverage with at least 1
ose of rotavirus vaccine was measured at age 5 months,
nd compared with coverage of other established child-
ood vaccines, DTaP and pneumococcal vaccine, given at the
ame age. To measure vaccine impact, we examined data
rom 2000-2009 on laboratory detections of rotavirus from
national network of ∼70 laboratories to assess trends and
iming of rotavirus activity. Data from a subset of 29 labo-
atories that consistently reported for ≥30 weeks for each
eason during 2000-2009 were used to measure national and
egional changes in rotavirus test results.
Results: By March 2009, coverage with 1 dose of rotavirus
t age 5 months has reached about 60%-70% across most
f the IIS sites, a level that is about 10%-20% lower than
hat of DTaP and pneumococcal vaccine. Concurrent with
ncreasing rotavirus vaccine coverage, rotavirus activity dur-
ng the 2007-2008 and 2008-2009 rotavirus seasons declined
y 64% and 60%, respectively, compared with pre-vaccine
ears during 2000-2006. In addition, compared with prevac-
ine years, the onset of both the 2007-2008 and 2008-2009
otavirus seasons was delayed by 11 weeks and 6 weeks,
espectively, and the seasons were shorter, lasting 14 and 17
eeks, respectively, compared with 26 weeks in 2000-2006.
egional differences in rotavirus activity were observed,
ith the West census region having a lower reduction and
ess delayed onset than all other regions in 2007-2008 and a
reater reduction andmore delayed onset than other regions
n 2008-2009.
Conclusion: Uptake of rotavirus vaccine in US chil-
ren has increased since vaccine implementation. However,
